調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023

細胞治療技術の世界市場予測（～2023年）

◆タイトル：Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023
◆商品コード：BT 6823
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年12月21日
◆ページ数：117
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,650 ⇒換算￥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥904,650見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

細胞治療技術の世界市場は、2018年の102億米ドルから2023年には199億米ドルに達し、この期間中14.4％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、細胞ベースの研究に対する政府の投資増加、GMP認証製造施設の増加、および腫瘍学を核とした細胞ベースの治療法・臨床試験などが考えられます。一方で、細胞ベースの研究の高コストと低い成功率が要因で、市場の成長は抑制される可能性があります。当調査レポートでは、細胞治療技術の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（消耗品、機器、ソフトウェア）分析、細胞の種類（ヒト幹細胞・分化細胞、動物細胞）分析、プロセス段階（細胞処理、細胞分配、細胞操作、品質管理）分析、エンドユーザー分析、細胞治療技術の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Global cell therapy instruments market to register a CAGR of 14.4% from 2018 to 2023”The global cell therapy instruments market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period. Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market. However, the high cost of cell-based research and low success rate are expected to restrain market growth during the forecast period.
“Consumables segment to account for the largest market share in 2018”
Based on the product, the cell therapy instruments market is segmented into consumables, equipment, and systems & software. In 2018, the consumables segment is expected to account for the largest share of the cell therapy instruments market. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

“Cell processing segment dominates the cell therapy instruments market during the forecast period”
Based on process, the cell therapy instruments market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest share of the market in 2018 and is expected to grow at the highest CAGR during the forecasted period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.
“Human cells to register the highest growth during the forecast period”
Based on cell type, the cell therapy instruments market is segmented into human cells and animal cells. In 2018, the human cells segment is expected to account for the largest share of the cell therapy instruments market. The rising adoption of human cells over animal cells for cell therapeutics research, technological advancements, and the rising incidence of diseases such as cancer and cardiac abnormalities are the key factors driving the growth of this segment.

“North America to command the largest share of the cell therapy instruments market in 2018”

The cell therapy instruments market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest market share in 2018. The increasing R&D activities in the pharmaceutical and biotechnology industries is one of the major factors driving the demand for cell therapy instruments in North America during the forecast period.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 – 20%, Tier 2 – 45%, and Tier 3 – 35%
• By Designation: C-level – 30%, Director-level – 20%, and Others – 50%
• By Region: North America – 35%, Europe – 24%, Asia Pacific – 25%, and the RoW – 16%

Major players in this market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).
Research Coverage
This report studies the cell therapy instruments market based on product, cells type, process, end user, and region. The report also analyzes factors (such as drivers, opportunities, and restraints) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell therapy instruments market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on cell therapy instruments offered by the top 10 players in the global cell therapy instruments market. The report analyzes the cell therapy instruments market by product, cell type, end user, process stage, and region

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell therapy instruments across key regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global cell therapy instruments market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the global cell therapy instruments market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKETS COVERED 15
1.2.2 YEARS CONSIDERED FOR THE STUDY 15
1.3 CURRENCY 16
1.4 LIMITATIONS 16
1.5 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 19
2.1.2.1 Key data from primary sources 20
2.2 MARKET SIZE ESTIMATION 21
2.2.1 BOTTOM-UP APPROACH 21
2.2.2 TOP-DOWN APPROACH 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 CELL THERAPY INSTRUMENTS: MARKET OVERVIEW 29
4.2 CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT & CELL TYPES (2018) 30
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL THERAPY INSTRUMENTS MARKET 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Rising government investments in cell-based research 33
5.2.1.2 Large number of oncology-oriented cell-based therapy clinical trials 33
5.2.1.3 Affordability and sustainability of advanced cell therapy instruments 34
5.2.2 RESTRAINTS 34
5.2.2.1 High cost of cell-based research and low success rate 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging countries 35
6 CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT 36
6.1 INTRODUCTION 37
6.2 CONSUMABLES 38
6.2.1 CONSUMABLES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL THERAPY INSTRUMENTS MARKET DURING THE FORECAST PERIOD 38
6.3 EQUIPMENT 39
6.3.1 CELL PROCESSING EQUIPMENT 40
6.3.1.1 Cell processing equipment are essential in laboratories and institutes for conducting research 40
6.3.2 SINGLE-USE EQUIPMENT 40
6.3.2.1 Technological advancements & the increasing demand for biological products to drive market growth 40
6.3.3 OTHER EQUIPMENT 41
6.4 SYSTEMS & SOFTWARE 42
6.4.1 CELL THERAPY SYSTEMS & SOFTWARE ARE USED TO MONITOR THE DIFFERENT STAGES OF CELL PROCESSING 42
7 CELL THERAPY INSTRUMENTS MARKET, BY PROCESS 43
7.1 INTRODUCTION 44
7.2 CELL PROCESSING 45
7.2.1 CELL PROCESSING MAKES THE HIGHEST USE OF CELL THERAPY INSTRUMENTS, WHICH IS A MAJOR GROWTH DRIVER OF THIS SEGMENT 45
7.3 CELL PRESERVATION, DISTRIBUTION, AND HANDLING 46
7.3.1 DEMAND GROWTH FOR CELL-BASED MEDICAL PRODUCTS AND THERAPIES TO DRIVE THE MARKET FOR RELIABLE STORAGE EQUIPMENT 46
7.4 PROCESS MONITORING AND QUALITY CONTROL 47
7.4.1 PROCESS MONITORING IS ESSENTIAL TO ENSURE THE QUALITY AND ACCURACY OF CELL PROCESSING 47
8 CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE 48
8.1 INTRODUCTION 49
8.2 HUMAN CELLS 50
8.2.1 STEM CELLS 51
8.2.1.1 Investments from venture capitalists for stem cell research are a major factor driving the growth of this market 51
8.2.2 DIFFERENTIATED CELLS 52
8.2.2.1 Increasing investments from market players to develop new and innovative products is a key factor driving market growth 52
8.3 ANIMAL CELLS 53
8.3.1 GROWING INVESTMENTS IN ANIMAL CELL RESEARCH IS A MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET 53
 
9 CELL THERAPY INSTRUMENTS MARKET, BY END USER 54
9.1 INTRODUCTION 55
9.2 LIFE SCIENCE RESEARCH COMPANIES 56
9.2.1 INCREASING NUMBER OF CELL-BASED EXPERIMENTS AND DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH 56
9.3 RESEARCH INSTITUTES 57
9.3.1 GROWING RESEARCH ACTIVITIES SUPPORTING THE GROWTH OF THIS END-USER SEGMENT 57
10 CELL THERAPY INSTRUMENTS MARKET, BY REGION 58
10.1 INTRODUCTION 59
10.2 NORTH AMERICA 60
10.2.1 US 62
10.2.1.1 US will continue to dominate the North American cell therapy instruments market during the forecast period 62
10.2.2 CANADA 64
10.2.2.1 High burden of chronic diseases to drive the adoption of cell therapy instruments in Canada 64
10.3 EUROPE 66
10.3.1 GERMANY 68
10.3.1.1 Germany to be the fastest-growing market for cell therapy instruments in Europe 68
10.3.2 UK 69
10.3.2.1 Rising prevalence of NCDs in the UK to drive market growth 69
10.3.3 REST OF EUROPE 71
10.4 ASIA PACIFIC 73
10.4.1 CHINA 75
10.4.1.1 Increasing cell therapy-based research to support market growth in China 75
10.4.2 JAPAN 77
10.4.2.1 Increasing geriatric population and subsequent growth in the disease burden to support market growth in Japan 77
10.4.3 REST OF ASIA PACIFIC 79
10.5 REST OF THE WORLD 81
11 COMPETITIVE LANDSCAPE 83
11.1 OVERVIEW 83
11.2 MARKET PLAYERS RANKING ANALYSIS, 2017 84
11.2.1 TOP PLAYERS IN THE CELL THERAPY INSTRUMENTS MARKET 84
11.3 COMPETITIVE SCENARIO 85
 
12 COMPANY PROFILES 87
(Business overview, Products offered, Recent developments & MnM View)*
12.1 THERMO FISHER SCIENTIFIC, INC. 87
12.2 MERCK KGAA 90
12.3 TERUMO BCT, INC. (A SUBSIDIARY OF TERUMO CORPORATION) 93
12.4 LONZA GROUP 95
12.5 GE HEALTHCARE 97
12.6 SARTORIUS 100
12.7 BECTON, DICKINSON AND COMPANY 102
12.8 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION) 104
12.9 MILTENYI BIOTEC GMBH 106
12.10 STEMCELL TECHNOLOGIES 108
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13 APPENDIX 110
13.1 INSIGHTS FROM INDUSTRY EXPERTS 110
13.2 DISCUSSION GUIDE 111
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 113
13.4 AVAILABLE CUSTOMIZATIONS 115
13.5 RELATED REPORTS 115
13.6 AUTHOR DETAILS 116

LIST OF TABLES

TABLE 1 NATIONAL INSTITUTES OF HEALTH (NIH) FUNDING IN THE US,
2013-2016 (USD MILLION) 33
TABLE 2 BREAKDOWN OF CURRENT ACTIVE CELL THERAPY CLINICAL TRIALS BY CELL GROUP AND TRIAL PHASE 35
TABLE 3 CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 37
TABLE 4 CELL THERAPY CONSUMABLES MARKET, BY REGION, 2016–2023 (USD MILLION) 38
TABLE 5 CELL THERAPY EQUIPMENT MARKET, BY REGION, 2016–2023 (USD MILLION) 39
TABLE 6 CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 39
TABLE 7 CELL PROCESSING EQUIPMENT MARKET, BY REGION, 2016–2023 (USD MILLION) 40
TABLE 8 SINGLE-USE EQUIPMENT MARKET, BY REGION, 2016–2023 (USD MILLION) 41
TABLE 9 CELL THERAPY MARKET FOR OTHER EQUIPMENT, BY REGION,
2016–2023 (USD MILLION) 41
TABLE 10 CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 42
TABLE 11 CELL THERAPY INSTRUMENTS MARKET, BY PROCESS, 2016–2023 (USD MILLION) 44
TABLE 12 CELL THERAPY INSTRUMENTS MARKET FOR CELL PROCESSING, BY REGION, 2016–2023 (USD MILLION) 45
TABLE 13 CELL THERAPY INSTRUMENTS MARKET FOR CELL PRESERVATION, DISTRIBUTION, AND HANDLING, BY REGION, 2016–2023 (USD MILLION) 46
TABLE 14 CELL THERAPY INSTRUMENTS MARKET FOR PROCESS MONITORING
AND QUALITY CONTROL, BY REGION, 2016–2023 (USD MILLION) 47
TABLE 15 CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 49
TABLE 16 CELL THERAPY INSTRUMENTS MARKET FOR HUMAN CELLS, BY REGION,
2016–2023 (USD MILLION) 50
TABLE 17 CELL THERAPY INSTRUMENTS MARKET FOR HUMAN CELLS, BY CELL TYPE,
2016–2023 (USD MILLION) 51
TABLE 18 CELL THERAPY INSTRUMENTS MARKET FOR STEM CELLS, BY REGION,
2016–2023 (USD MILLION) 51
TABLE 19 CELL THERAPY INSTRUMENTS MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2016–2023 (USD MILLION) 52
TABLE 20 CELL THERAPY INSTRUMENTS MARKET FOR ANIMAL CELLS, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 21 CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 55
TABLE 22 CELL THERAPY INSTRUMENTS MARKET FOR LIFE SCIENCE RESEARCH COMPANIES, BY REGION, 2016–2023 (USD MILLION) 56
TABLE 23 CELL THERAPY INSTRUMENTS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2016–2023 (USD MILLION) 57
TABLE 24 CELL THERAPY INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 25 NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 61
TABLE 26 NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 61
TABLE 27 NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 61
TABLE 28 NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 62
TABLE 29 NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 62
TABLE 30 US: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 63
TABLE 31 US: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 63
TABLE 32 US: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 63
TABLE 33 US: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 64
TABLE 34 CANADA: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 64
TABLE 35 CANADA: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 65
TABLE 36 CANADA: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 65
TABLE 37 CANADA: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 65
TABLE 38 EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 66
TABLE 39 EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 66
TABLE 40 EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 67
TABLE 41 EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 67
TABLE 42 EUROPE: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 67
TABLE 43 GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 68
TABLE 44 GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 68
TABLE 45 GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 69
TABLE 46 GERMANY: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 69
TABLE 47 UK: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 70
TABLE 48 UK: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 70
TABLE 49 UK: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 70
TABLE 50 UK: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 71
TABLE 51 ROE: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 71
TABLE 52 ROE: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 72
TABLE 53 ROE: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 72
TABLE 54 ROE: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 72
TABLE 55 ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 74
TABLE 56 ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 74
TABLE 57 ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 74
TABLE 58 ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 75
TABLE 59 ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 75
TABLE 60 CHINA: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 76
TABLE 61 CHINA: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 76
TABLE 62 CHINA: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 76
TABLE 63 CHINA: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 77
TABLE 64 JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 78
TABLE 65 JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 78
TABLE 66 JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 78
TABLE 67 JAPAN: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 79
TABLE 68 ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 79
TABLE 69 ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 80
TABLE 70 ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 80
TABLE 71 ROAPAC: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 80
TABLE 72 ROW: CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 81
TABLE 73 ROW: CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2016–2023 (USD MILLION) 81
TABLE 74 ROW: CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2016–2023 (USD MILLION) 82
TABLE 75 ROW: CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2016–2023 (USD MILLION) 82


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 19
FIGURE 3 CELL THERAPY INSTRUMENTS MARKET: BOTTOM-UP APPROACH 21
FIGURE 4 CELL THERAPY INSTRUMENTS MARKET: TOP-DOWN APPROACH 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 23
FIGURE 6 CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT,
2018 VS. 2023 (USD MILLION) 25
FIGURE 7 CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE,
2018 VS. 2023 (USD MILLION) 26
FIGURE 8 CELL THERAPY INSTRUMENTS MARKET, BY PROCESS,
2018 VS. 2023 (USD MILLION) 26
FIGURE 9 CELL THERAPY INSTRUMENTS MARKET, BY END USER,
2018 VS. 2023 (USD MILLION) 27
FIGURE 10 CELL THERAPY INSTRUMENTS MARKET, BY REGION,
2018 VS. 2023 (USD MILLION) 28
FIGURE 11 RISING GOVERNMENT INVESTMENT FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 29
FIGURE 12 CONSUMABLES AND HUMAN CELLS TO DOMINATE THE CELL THERAPY INSTRUMENTS MARKET IN 2018 30
FIGURE 13 COUNTRIES IN ASIA TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 31
FIGURE 14 CELL THERAPY INSTRUMENTS MARKET: DRIVERS, RESTRAINTS,
AND OPPORTUNITIES 32
FIGURE 15 CELL THERAPY CONSUMABLES TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD (2018–2023) 37
FIGURE 16 CELL PROCESSING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 44
FIGURE 17 HUMAN CELLS TO WITNESS THE HIGHEST GROWTH IN THE CELL THERAPY INSTRUMENTS MARKET DURING THE FORECAST PERIOD 49
FIGURE 18 LIFE SCIENCE RESEARCH COMPANIES TO BE THE LARGEST END-USER SEGMENT IN THE CELL THERAPY INSTRUMENTS MARKET 55
FIGURE 19 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE CELL THERAPY INSTRUMENTS MARKET DURING THE FORECAST PERIOD 59
FIGURE 20 NORTH AMERICA: CELL THERAPY INSTRUMENTS MARKET SNAPSHOT 60
FIGURE 21 ASIA PACIFIC: CELL THERAPY INSTRUMENTS MARKET SNAPSHOT 73
FIGURE 22 KEY DEVELOPMENTS IN THE CELL THERAPY INSTRUMENTS MARKET
FROM 2015 TO 2018 83
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 87
FIGURE 24 MERCK KGAA: COMPANY SNAPSHOT 90
FIGURE 25 TERUMO CORPORATION: COMPANY SNAPSHOT 93
 
FIGURE 26 LONZA GROUP: COMPANY SNAPSHOT 95
FIGURE 27 GE HEALTHCARE: COMPANY SNAPSHOT 97
FIGURE 28 SARTORIUS: COMPANY SNAPSHOT 100
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 102
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT 104


★調査レポート[細胞治療技術の世界市場予測（～2023年）] ( Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023 / BT 6823) 販売に関する免責事項
[細胞治療技術の世界市場予測（～2023年）] ( Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023 / BT 6823) についてEメールでお問い合わせ
◆関連調査資料◆
  • 幹細胞アッセイの世界市場予測（～2023年）
    MAM-BT-4628 / MarketsandMarkets / 2018年3月28日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、細胞タイプ別分析、製品別分析、用途別分析、幹細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments. The global stem cell assay market is segmented by type, cell type, product & service, application, end user, and region. By type, the market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The viability/cytotoxicity segment accounted for the largest market share of the...
  • 幹細胞製造の世界市場予測（～2023年）：HSC、MSC、iPSC、ESC、装置、培地、消耗品
    BT-6089 / MarketsandMarkets / 2018年3月13日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞製造の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、用途別分析、需要先別分析、地域別分析、幹細胞製造の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market. This report broadly segments the stem cell manufacturing market...
  • 細胞生存率アッセイの世界市場予測（～2023年）：MTTアッセイ、XTTアッセイ、カルセイン、レサズリン、フローサイトメトリー、分光光度計
    BT-6577 / MarketsandMarkets / 2018年9月5日 / MarketsandMarketsが発行した当調査レポートでは、細胞生存率アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（MTTアッセイ、XTTアッセイ、カルセイン、レサズリン、フローサイトメトリー、分光光度計）分析、細胞タイプ（ヒト、動物、微生物）分析、用途（基礎研究、幹細胞、創薬・開発）分析、細胞生存率アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell viability assays market is projected to reach USD 4.16 billion by 2023 from USD 2.78 billion in 2018, at a CAGR of 8.4%. Factors contributing to the growth of this market include the rising incidence and prevalence of chronic and infectious diseases, growing availability of funds for research, rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics. The report analyzes the global cell viability assays market by product, cell type, application, end user, and region. On the basis of product, the consumables segment is expected to account for the largest...
  • 幹細胞バンキングの世界市場予測（～2023年）
    BT4447 / MarketsandMarkets / 2018年5月15日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞バンキングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、ソース別分析、サービス種類別分析、用途別分析、地域別分析、幹細胞バンキングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell banking market is projected to reach USD 9.30 Billion by 2023 from USD 6.28 Billion in 2018, at a CAGR of 8.2%. Factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research are driving the growth of the market. This report broadly categorizes the global stem cell banking market into source, application, service type, and region/country. Based on source, the stem cell banking market is segmented into...
  • 初代細胞の世界市場予測（～2023年）：造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉
    BT6489 / MarketsandMarkets / 2018年7月31日 / MarketsandMarketsが発行した当調査レポートでは、初代細胞の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別（ヒト、動物）分析、由来別（造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉）分析、エンドユーザー別（ライフサイエンス研究、研究機関）分析、初代細胞の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%. Growth in the primary cells market is mainly driven by factors such as increasing cancer research; the advantages of primary human cells over cell lines; the increasing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries, partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing. The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung,...
  • 細胞表面マーカーの世界市場予測（～2023年）
    BT 6815 / MarketsandMarkets / 2018年12月18日 / 細胞表面マーカーの世界市場は、2018年の5億2,000万ドルから2023年には7億6,900万ドルに達し、この期間中8.1％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、主にがんの世界的な罹患率の上昇、ライフサイエンス研究への資金提供の増加、そして幹細胞研究および神経生物学研究の伸びが考えられます。一方で、抗体開発プロセスに費用および時間がかかることにより、市場の成長が抑制される可能性があります。当調査レポートでは、細胞表面マーカーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（抗体、PCRアレイ）分析、ソース（マウス、ラット）分析、細胞の種類（T細胞、B細胞、NK細胞）分析、用途（研究、臨床）分析、細胞表面マーカーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“High global prevalence of cancer is expected to drive the overall growth of the cell surface markers market”The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period. The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and growth in stem cell and neurobiology research. On the other hand, factors such as the costly and time-intensive antibody development process may hinder the growth of this market in the coming years....
  • アポトーシスアッセイの世界市場予測（～2023年）
    BT-6742 / MarketsandMarkets / 2018年11月14日 / アポトーシスアッセイの世界市場は、2018年の推定36億米ドルから2023年には59億米ドルに達し、10.5%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、慢性疾患および感染症の発生率および罹患率の増加、がん研究への資金提供の増加、細胞ベースの研究の増加、およびアポトーシス調節剤の開発が考えれられます。一方で、研究開発に必要な投資が多額にのぼることにより、市場の成長が抑制される可能性があります。当調査レポートでは、アポトーシスアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（カスパーゼ、アネキシンV、DNA断片化、ミトコンドリアアッセイ）分析、検出技術（フローサイトメトリー、蛍光顕微鏡）分析、用途（幹細胞、創薬・開発、臨床研究）分析、アポトーシスアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global apoptosis assays market is projected to grow at a CAGR of 10.5%”The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%. The rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs are the key drivers for market growth. However, high investments required for research and development is expected to restrain the growth of this market to a certain extent during the forecast period. “The flow cytometry segment to witness...
  • 粒子線治療の世界市場予測（～2023年）
    MD-6747 / MarketsandMarkets / 2018年11月16日 / 粒子線治療の世界市場は、2018年の8億6500万米ドルから2023年には13億4900万米ドルに達し、9.3％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、粒子線治療が光子療法よりも優れていること、世界中でがんの罹患率が拡大していること、臨床試験において粒子線治療の採用が増加していること、世界中で粒子線治療センターが増加していることなどが考えれられます。当調査レポートでは、粒子線治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、タイプ（重粒子イオン、陽子線治療）分析、製品（サイクロトロン、シンクロトロン、シンクロサイクロトロン）分析、サービス分析、システム（シングルルーム、マルチルーム）分析、粒子線治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The particle therapy market is projected to grow at a CAGR of 9.3% during the forecast period”The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. The growth of this market is largely driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. “The cyclotrons segment is expected to account for the largest market share during the forecast...
  • 細胞解離の世界市場予測（～2023年）：酵素系（コラゲナーゼ、トリプシン、DNase、エラスターゼ）、非酵素系
    MAM-BT-6129 / MarketsandMarkets / 2018年3月28日 / MarketsandMarketsが発行した当調査レポートでは、細胞解離の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、種類別分析、組織別分析、需要先別分析、細胞解離の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell dissociation market is expected to reach USD 440.5 Million by 2023 from USD 241.2 Million in 2018, at a CAGR of 12.8%. Market growth is primarily driven by the rising R&D investments in the life sciences industry, increasing research on chronic diseases and rising government funding for cancer research. The global cell dissociation market is segmented by product, tissue, type, end user, and region. By product, the cell dissociation market segmented into enzymatic dissociation products, non-enzymatic dissociation products and instruments & accessories. The enzymatic dissociation products segment estimated to account for the largest market of the global...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆